Dr. Manish Kantilal Gala, MD

Dr. Gala practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Gala's NPI, 1033399357, was assigned on November 5, 2007. Dr. Gala graduated from Harvard Medical School in 2007. Dr. Gala holds Massachusetts license 260363.

Dr. Gala's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Gala's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Gala is also affiliated with Salem Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Gala to 1 more hospital, 2 medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gala practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gala's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Gala's licenses on file in 2 states: Massachusetts and California.

CMS data shows 295 Medicare services from Dr. Gala across 8 procedure codes in 2024, for 268 Medicare patients. Medicare paid $41,825 for them. Every service was in an office.

CMS counts 268 Medicare patients who saw Dr. Gala in 2024. The largest group is 65 to 74, with 126 patients. 69% of them have high cholesterol, and 63% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gala's median patient age at 71, with 53% women.

In 2024, Dr. Gala wrote 432 Medicare Part D claims for 241 patients. 75% of them were for generic drugs. CMS names the drug for 341 of them, across 5 drugs with 11 or more claims each, at $58,208 in total drug cost. In 2023, CMS named 227 claims across 7 drugs.

Dr. Gala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gala as offering telehealth. CMS counts 125 procedures of colonoscopy by Dr. Gala, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 44 papers to Dr. Gala, published from 2012 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Colorectal Neoplasms, Genetic Predisposition to Disease and Genome-Wide Association Study. Dr. Gala has published most often in Clin Transl Gastroenterol. Dr. Gala's most frequent co-authors are Keith E. Curtis, MD, Daniel C. Chung, MD and Charles Stewart Fuchs, MD, MPH.

CMS Open Payments shows 4 general payments to Dr. Gala from 3 drug and device companies from 2016 to 2022. Accredited education speaker fees make up the largest share, 39% of the total. Merrimack Pharmaceuticals, Inc. paid the most, $400.

Dr. Gala graduated from Harvard Medical School in 2007.